[Introduction to food allergy].

Ignacio Javier Ansotegui Zubeldia, Alessandro Fiocchi
{"title":"[Introduction to food allergy].","authors":"Ignacio Javier Ansotegui Zubeldia, Alessandro Fiocchi","doi":"10.29262/ram.v70i4.1308","DOIUrl":null,"url":null,"abstract":"<p><p>Food allergy is a common chronic disorder that affects infants, children, adolescents, and adults. The prevalence of food allergy has increased in recent decades throughout the world, not limited to Western countries. Since there is no treatment, this focuses on avoiding allergens, in addition to educating patients and caregivers in the emergency treatment of acute reactions, for example: application of epinephrine. Studies suggest that accidental reactions occur in about 45% of children with food allergies each year, although most reactions are mild or moderate in severity. Hospital admissions for food anaphylaxis vary from 4 to 20 per 100,000 inhabitants; Deaths are rare, with an estimated incidence of 0.03 to 0.3 per million people with food allergy. Death from food anaphylaxis is rare and appears to have remained stable, possibly due to increases in food allergen labeling, diagnostic services, rates of intramuscular epinephrine prescription, and awareness of food allergies. Omalizumab is a drug approved for several disorders (chronic hives or difficult asthma) and may help reduce symptoms associated with food allergy. The relative importance of alternative technologies, management strategies and policies for food allergy varies from one region to another, due to differences in the epidemiology, education, socioeconomic well-being, and cultural preferences of the population.</p>","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29262/ram.v70i4.1308","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Food allergy is a common chronic disorder that affects infants, children, adolescents, and adults. The prevalence of food allergy has increased in recent decades throughout the world, not limited to Western countries. Since there is no treatment, this focuses on avoiding allergens, in addition to educating patients and caregivers in the emergency treatment of acute reactions, for example: application of epinephrine. Studies suggest that accidental reactions occur in about 45% of children with food allergies each year, although most reactions are mild or moderate in severity. Hospital admissions for food anaphylaxis vary from 4 to 20 per 100,000 inhabitants; Deaths are rare, with an estimated incidence of 0.03 to 0.3 per million people with food allergy. Death from food anaphylaxis is rare and appears to have remained stable, possibly due to increases in food allergen labeling, diagnostic services, rates of intramuscular epinephrine prescription, and awareness of food allergies. Omalizumab is a drug approved for several disorders (chronic hives or difficult asthma) and may help reduce symptoms associated with food allergy. The relative importance of alternative technologies, management strategies and policies for food allergy varies from one region to another, due to differences in the epidemiology, education, socioeconomic well-being, and cultural preferences of the population.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[食物过敏简介]
食物过敏是一种常见的慢性疾病,影响婴儿、儿童、青少年和成年人。近几十年来,食物过敏症的发病率在全世界范围内不断上升,不仅限于西方国家。由于没有治疗方法,因此除了教育患者和护理人员如何紧急处理急性反应(如使用肾上腺素)外,重点是避免接触过敏原。研究表明,每年约有 45% 的食物过敏儿童会发生意外反应,但大多数反应的严重程度为轻度或中度。食物过敏性休克的入院率为每 10 万居民中 4 到 20 例;死亡很少见,估计每百万食物过敏患者中只有 0.03 到 0.3 例死亡。食物过敏性休克导致死亡的情况很少见,而且似乎保持稳定,这可能是由于食物过敏原标签、诊断服务、肌肉注射肾上腺素处方率以及对食物过敏的认识有所提高。奥马珠单抗是一种获准用于治疗多种疾病(慢性荨麻疹或难治性哮喘)的药物,可能有助于减轻与食物过敏有关的症状。由于流行病学、教育、社会经济福利和人口文化偏好的差异,不同地区对食物过敏的替代技术、管理策略和政策的相对重要性也不尽相同。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
[Adenovirus-related acute liver failure treated with intravenous immunoglobulin]. [Allergic contact dermatitis due to Furacin®]. [Chronic urticaria as an atypical reaction after a vespid bite]. [Epidemiological profile of allergic respiratory disease in Mexican children]. [Knowledge of mothers of children under 5 years of age about vaccination schedule].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1